PRME
Prime Medicine Inc
3월 13일 4:00 PM ET (한국 3/14 05:00)
$3.65
-0.08 ▼ -2.14%
🌙 3월 13일 7:39 PM ET (한국 3/14 08:39)
$3.66
+0.01 ▲ +0.27%
| Index | RUT | P/E | - | EPS (ttm) | -1.37 | Insider Own | 47.66% | Shs Outstand | 0.18B | Perf Week | -8.98% |
| Market Cap | 0.66B | Forward P/E | - | EPS next Y | 10.41% | Insider Trans | - | Shs Float | 0.09B | Perf Month | 5.8% |
| Enterprise Value | 0.60B | PEG | - | EPS next Q | -0.25 | Inst Own | 41.34% | Short Float | 28.83% | Perf Quarter | -15.7% |
| Income | -0.20B | P/S | 142.34 | EPS this Y | 32.32% | Inst Trans | 5.45% | Short Ratio | 8.38 | Perf Half Y | -10.54% |
| Sales | 0.00B | P/B | 5.45 | EPS next 5Y | 16.43% | ROA | -36.35% | Short Interest | 27.25M | Perf YTD | 5.19% |
| Book/sh | 0.67 | P/C | 3.71 | EPS past 3/5Y | 2.55% -91.28% | ROE | -146.81% | 52W High | -47.41% ($6.94) | Perf Year | 112.21% |
| Cash/sh | 0.98 | P/FCF | - | Sales past 3/5Y | - -2.32% | ROIC | -87.77% | 52W Low | 228.83% ($1.11) | Perf 3Y | -74.26% |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | 19.04% | Gross Margin | -58.05% | Volatility(W/M) | 9.86% 8.36% | Perf 5Y | - |
| Dividend TTM | - | EV/Sales | 129.11 | Sales Y/Y TTM | 55.28% | Oper. Margin | -4498.06% | ATR (14) | 0.33 | Perf 10Y | - |
| Dividend Ex-Date | - | Quick Ratio | 4.84 | EPS Q/Q | 28.39% | Profit Margin | -4342.44% | RSI (14) | 44.12 | Recom | 1.4 |
| Dividend Gr. 3/5Y | - | Current Ratio | 4.84 | Sales Q/Q | -61.61% | SMA20 | -5.34% ($3.86) | Beta | 2.64 | Target Price | $7.57 |
| Payout | - | Debt/Eq | 0.96 | Earnings | 3000000 | SMA50 | -5.51% ($3.86) | Rel Volume | 0.68 | Prev Close | $3.73 |
| Employees | 146 | LT Debt/Eq | 0.9 | EPS/Sales Surpr. | 12.49% -34.6% | SMA200 | -5.71% ($3.87) | Avg Volume(3M) | 3.25M | Price | $3.65 |
| IPO | 2022/10/20 | Option/Short | Yes/Yes | Trades | 8748 | Volume | 2,216,283 | Change | -2.14% |
뉴스 로딩 중...